Previous close | 300.00 |
Open | 300.00 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 630.00 |
Expiry date | 2026-01-16 |
Day's range | 300.00 - 300.00 |
Contract range | N/A |
Volume | |
Open interest | 52 |
A US Food and Drug Administration (FDA) panel voted unanimously 11-0 to recommend the approval of Eli Lilly's (LLY) Alzheimer's drug, donanemab. Yahoo Finance's Anjalee Khemlani reports more on the story and the drug's ability to slow cognitive decline. Read more about donanemab here. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl
Apple shares trade lower after the tech giant unveils its long-awaited approach to generative artificial intelligence, GM’s board authorizes a new $6 billion buyback plan, and Yext tumbles after reporting a wider first-quarter loss. Oracle, meanwhile, is scheduled to report quarterly earnings after the closing bell Tuesday.
The latest investor updates on stocks that are trending on Tuesday